{"id":"W3112986797","doi":"10.1007/s40264-020-01008-0","title":"Effective Pharmacovigilance System Development: EFPIA-IPVG Consensus Recommendations","year":2020,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Pharmacovigilance; Legislation; Medicine; Scope (computer science); Benchmarking; European union; Obligation; Business; Marketing authorization; Risk analysis (engineering); Pharmacology; Marketing; International trade; Political science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0012461,0.001294603,0.002859729,0.0003738934,0.001261113,0.00006190377,0.0009516236,0.0007631177,0.001023086],"category_scores_gemma":[0.0001358769,0.001233042,0.000916236,0.001094379,0.0002555433,0.0001850664,0.000342241,0.003859574,0.00698342],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001523129,"about_ca_system_score_gemma":0.001353972,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001203435,"about_ca_topic_score_gemma":0.000006909316,"domain_scores_codex":[0.9931334,0.002303443,0.001794392,0.00130949,0.0003528827,0.001106374],"domain_scores_gemma":[0.99453,0.0028093,0.001145518,0.0004940795,0.0001766173,0.0008444389],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001478764,0.000218713,0.00001020451,0.01107863,0.002017542,0.0003510615,0.0006185509,0.00004515491,0.00001971863,0.0006270648,0.04847304,0.9363924],"study_design_scores_gemma":[0.001550158,0.00001601797,0.000002331373,0.003736527,0.002718391,0.0002891895,0.0002201395,0.0002506687,0.0002296636,0.000005509003,0.989801,0.001180415],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000009550375,0.9572593,0.00009774212,0.0008401588,0.006054416,0.003634214,0.002533499,0.001007013,0.02856413],"genre_scores_gemma":[0.0003675252,0.990924,0.0003419784,0.001199494,0.001462205,0.001361438,0.001675625,0.0001929643,0.002474766],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9413279,"threshold_uncertainty_score":0.9999806,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1345349921506546,"score_gpt":0.4755382153208398,"score_spread":0.3410032231701852,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}